SmartTRAK Life Sciences News and Analysis Blog in the Orthopedics, Wound, and Neuro Therapies Market Segments
.png)
SmartTRAK interviews Oxford Performance Materials CEO Scott DeFelice to learn more about the company’s P...
Headwinds persist for the Arthroscopic Technologies Market in Q322 With most of the major headwinds caus...
With the recent announcement that 3M is spinning off its Health Care division, SmartTRAK looks back at t...
SmartTRAK reports that Q322 Spine Market performance drove a lack of consensus on operational performanc...
SmartTRAK takes a look back at Neuromodulation Trends in 2022 and looks forward to reporting on emerging...
Biosynthetic hernia matrices continue their ascent and Xenograft hernia matrices grow, thanks to TELA Bi...
Despite declining OUS results, the US Trauma Market experienced healthy growth attributed to adoption of...
Growth in the SCS and DBS segments remained soft in Q322 as companies continue to wrestle with macro-env...
Surgeons are concerned about the cost of breast matrices in an increasingly restrictive environment, but...
Q322 sees a tidal wave of new robotic spine surgery competitors as well as data-driven initiatives under...
Login